Remi Meds review

Take a quarter dose here and it costs you less — 29% less than the rungs at a full milligram and above — and you can confirm that on the homepage without a quiz, an email address or an account. Five rungs for each molecule, each printing a weekly milligram against a monthly price, is the clearest answer to the cost-per-dose question anywhere here. Everything is billed monthly with no prepay rungs and no first-month teaser, so the number you see is the number you pay. Two things will cost you. Its pages never actually name the molecule — you are buying something called a personalized GLP-1, and which drug that is has to be inferred from the ladder and the page address. And the outcome claims are printed as product bullets with no study, duration or population attached, so treat them as marketing rather than as evidence.

Vs median

$74/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Quotes off the lowest dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

Remi Meds does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Remi Meds prices its GLP-1 plans by milligrams per week and publishes the whole ladder on its homepage under "Dosage Options" — five rungs for each molecule, each with a weekly milligram figure against a monthly price, with no quiz or account in the way. Everything is billed monthly, with no intro rate and no prepay rungs. It also sells sermorelin and NAD+, quoted in milliliters rather than milligrams. It names its prescribing network and publishes a LegitScript ID, but names no pharmacy and publishes no state list.

THE RENDERED COPY NEVER NAMES THE MOLECULE. What you buy is "Personalized GLP-1" or "Personalized GLP-1/GIP +B12"; which drug that is can only be inferred from the milligram ladder and the page address

• The sermorelin and NAD+ rungs are quoted in milliliters rather than milligrams — "SERMORELIN 3 ml per week | $249/mo" — so those ladders carry no dose information at all
• "Achieve up to 15% body weight reduction" and "up to 25%" are printed as product bullets rather than as trial findings, with no study, duration or population attached
• The comparison table asserts "Minimize Nausea" and "Less Side effects" as features Remi's plans have and others do not, which is not a checkable claim
• No compounding pharmacy is named — only "our trusted pharmacy partners" — and no list of states served is published
• No week count is published behind "Billed monthly"
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Remi Meds is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan